We are live on ! Find out more
CIS

Capital International Sarl Portfolio holdings

AUM $6.11B
1-Year Est. Return 32.29%
This Fund
S&P 500
This Quarter Est. Return
-2.39%
1 Year Est. Return
+32.29%
3 Year Est. Return
+120.6%
5 Year Est. Return
+165.23%
10 Year Est. Return
+684.77%
AUM
$6.11B
AUM Growth
-$120M
Cap. Flow
+$247M
Cap. Flow %
4.04%
Top 10 Hldgs %
34.1%
Holding
330
New
30
Increased
139
Reduced
105
Closed
43

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$176M
2
NVDA icon
NVIDIA
NVDA
+$61.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$42.5M
4
APH icon
Amphenol
APH
+$36.1M
5
RPRX icon
Royalty Pharma
RPRX
+$22.5M

Top Sells

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$40.6M
2
FLUT icon
Flutter Entertainment
FLUT
+$28.8M
3
AVGO icon
Broadcom
AVGO
+$23.6M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$22.5M
5
ECL icon
Ecolab
ECL
+$21.8M

Sector Composition

Rank Sector Weight
1 Technology 24.91%
2 Healthcare 15.18%
3 Consumer Discretionary 13.77%
4 Communication Services 11.89%
5 Industrials 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NET icon
26
Cloudflare
NET
$99B
$57.6M 0.94%
278,952
+32,747
+13% +$6.24M
ISRG icon
27
Intuitive Surgical
ISRG
$127B
$55.7M 0.91%
120,863
+6,342
+6% +$3.21M
ASML icon
28
ASML
ASML
$626B
$55.6M 0.91%
42,072
-10,898
-21% -$14.9M
TSM icon
29
TSMC
TSM
$2.1T
$54.9M 0.9%
162,575
+6,284
+4% +$2.16M
DE icon
30
Deere & Co
DE
$160B
$53.8M 0.88%
95,506
+20,208
+27% +$11.4M
MA icon
31
Mastercard
MA
$506B
$53.6M 0.88%
107,299
-3,317
-3% -$1.75M
ONC
32
BeOne Medicines Ltd
ONC
$32.8B
$51.6M 0.85%
173,879
+21,364
+14% +$6.92M
RPRX icon
33
Royalty Pharma
RPRX
$25.9B
$50.3M 0.82%
1,048,202
+513,306
+96% +$22.5M
KLAC icon
34
KLA
KLAC
$239B
$49.4M 0.81%
335,200
+470
+0.1% +$68.8K
JPM icon
35
JPMorgan Chase
JPM
$935B
$49.3M 0.81%
167,536
-48,217
-22% -$14.6M
LIN icon
36
Linde
LIN
$221B
$49.2M 0.81%
99,195
+3,833
+4% +$1.81M
QSR icon
37
Restaurant Brands International
QSR
$25.7B
$48.1M 0.79%
650,735
+179,058
+38% +$12.6M
TDG icon
38
TransDigm Group
TDG
$70.2B
$47.4M 0.78%
40,890
+3,985
+11% +$5.22M
WELL icon
39
Welltower
WELL
$169B
$47.3M 0.77%
239,169
+88,495
+59% +$17.5M
APH icon
40
Amphenol
APH
$198B
$46.4M 0.76%
367,122
+256,527
+232% +$36.1M
C icon
41
Citigroup
C
$222B
$46.2M 0.76%
407,780
+6,733
+2% +$767K
RYAAY icon
42
Ryanair
RYAAY
$30.4B
$44M 0.72%
761,948
+56,852
+8% +$3.75M
TMO icon
43
Thermo Fisher Scientific
TMO
$213B
$43.9M 0.72%
89,414
-17,121
-16% -$9.29M
FTAI icon
44
FTAI Aviation
FTAI
$21.1B
$40.3M 0.66%
164,413
+14,212
+9% +$3.76M
DB icon
45
Deutsche Bank
DB
$69B
$38.9M 0.64%
1,332,396
-226,841
-15% -$7.99M
GEV icon
46
GE Vernova
GEV
$264B
$35.5M 0.58%
40,696
+4,810
+13% +$3.75M
AJG icon
47
Arthur J. Gallagher & Co
AJG
$64.1B
$34M 0.56%
156,934
+5,645
+4% +$1.3M
AMGN icon
48
Amgen
AMGN
$208B
$33.3M 0.54%
94,516
+6,630
+8% +$2.36M
CVE icon
49
Cenovus Energy
CVE
$55.7B
$33M 0.54%
1,247,752
-147,303
-11% -$3.14M
TCOM icon
50
Trip.com Group
TCOM
$29.6B
$32.9M 0.54%
660,014
+14,771
+2% +$861K
1
2
3 4 5

Similar funds

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Capital International Sarl's Q1 2026 Portfolio in Review

As of Q1 2026, Capital International Sarl held 330 positions worth $6.11B, down 1.9% from $6.23B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Capital International Sarl deployed $247M of net new capital in Q1 2026, opening 30 new positions and adding to 139 existing holdings. Its largest new stake was AstraZeneca: 914,752 shares worth $178M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Broadcom, an estimated $23.6M trimmed.

  • Capital International Sarl's largest Q1 2026 buy was AstraZeneca: 914,752 shares worth $178M.
  • Capital International Sarl added most to NVIDIA in Q1 2026, an estimated $61.1M increase.
  • Capital International Sarl's biggest Q1 2026 reduction was Broadcom, cutting an estimated $23.6M.
  • Capital International Sarl fully exited Synopsys in Q1 2026, selling an estimated $40.6M.
  • Capital International Sarl's ten largest holdings make up 34% of its $6.11B portfolio in Q1 2026.
  • Capital International Sarl opened 30 new positions and closed 43 in Q1 2026.
  • Capital International Sarl's portfolio value fell 1.9% quarter-over-quarter to $6.11B.

Based on Capital International Sarl's 13F filing for Q1 2026, filed 13 May 2026.